New CEO for growing health tech specialist

Experienced business leader Jon Pickering has joined the firm with over two

decades of technology and telecoms expertise, from high-growth healthcare and

software as a service (SaaS) environments.

With a proven track record of shaping strategic growth, his appointment

coincides with the promotion of head of software engineering Andrew Leeks –

who now assumes the role of Chief Technology Officer (CTO) – and former head

of transformation Lisa Harris, who has advanced to Chief Operations Officer

(COO).

An acting head of marketing is also now in post, with a business development

vacancy currently live and further technical hires earmarked for the New Year.

Graham Ridgway – an established non-executive director with an acclaimed CV

– remains the company Chairman, having been appointed to the position in

January 2021; Jennie Costello continues in her role as Chief Finance Officer (CFO)

and long-standing colleague Jamie Hall maintains his focus as Head of Sales.

Already leading the way in the digital transformation of paper medical records,

Chelmsford-headquartered IMMJ is currently working with 20 UK NHS Trusts.

Customers of IMMJ’s award-winning MediViewer product, include Imperial

College Healthcare NHS Trust, The Hillingdon Hospitals NHS Foundation Trust, and

integrated health and care service provider for the Isle of Man Government, Manx

Care – to name just a few. In total, IMMJ already securely handles over 1 billion

healthcare images for UK patients.

Under the leadership of the new executive team, IMMJ has ambitions to acquire

30 additional customers by the end of the 2026 financial year, which will see

annual recurring revenue rise to £6m.

Commenting on the moves, Jon Pickering said: “In relative terms, IMMJ remains a

young health tech firm, having been established in only 2015. However, backed by

investment from Foresight – and with an incredible pedigree of committed talent

from the healthcare sector – the business has grown quickly.

“It was apparent last year that a new commercial strategy was required – not

only to drive the organisation forward to reach its full potential, but to better

enable the rapid digitisation of clinical content for use at the point of care. This is

a complex eco-system – not least because of red tape surrounding funding, and

the marked digital maturity differences from one Trust to the next. However, the

succession plan for IMMJ – which saw the four founding directors fully exit the

business and a new exec team take shape – means we are ambitious about our

plans for the years ahead.

Graham Ridgway added: “Jon is an energetic and inspiring tech leader with a

passion for fuelling collaboration not only within his own organisation, but among

the wider supply chain. He is acutely aware of the challenges and opportunities

within the healthcare sector, and the advantages that digitisation can bring.

“He’s recognised that we don’t just have an ambitious product roadmap – we

have a number of loyal brand advocates both within our team and our customer

base too. Their experience in the complex healthcare environment and their

shared vision for the future of the sector, gives us the perfect platform for

accelerated growth in 2023 and beyond.”